ArticleChemical communications (Cambridge, England)2015
Selective targeting of Mycobacterium smegmatis with trehalose-functionalized nanoparticles.
Article in Chemical communications (Cambridge, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 43 citations in OpenAlex.
- Trehalose-Functionalized Magnetic Affinity Probe Provides Biochemical Evidence of Nanoparticle Internalization in Mycobacteria.ACS infectious diseases · 2025Article
- Turning on the Antimicrobial Activity of Gold Nanoclusters Against Multidrug-Resistant Bacteria.Angewandte Chemie (International ed. in English) · 2023Article
- A Bifunctional Chemical Reporter for in Situ Analysis of Cell Envelope Glycan Recycling in Mycobacteria.ACS infectious diseases · 2022Article
- Design and Synthesis of Visible-Light-Responsive Azobenzene Building Blocks for Chemical Biology.The Journal of organic chemistry · 2022Article
- Trehalose-Modified Silver Nanoparticles as Antibacterial Agents with Reduced Cytotoxicity and Enhanced Uptake by Mycobacteria.ACS applied nano materials · 2022Article
- Synthesis and Application of Trehalose Materials.JACS Au · 2022Review
- Nanomaterials Aiming to Tackle Antibiotic-Resistant Bacteria.Pharmaceutics · 2022Review
- Chemical Reporters for Bacterial Glycans: Development and Applications.Chemical reviews · 2022Review
- Selective strategies for antibacterial regulation of nanomaterials.RSC advances · 2022Review
- Maltoheptaose-Presenting Nanoscale Glycoliposomes for the Delivery of Rifampicin toACS applied nano materials · 2021Article
- Recent Developments in the Use of Glyconanoparticles and Related Quantum Dots for the Detection of Lectins, Viruses, Bacteria and Cancer Cells.Frontiers in chemistry · 2021Review
- Antimycobacterial Effect of Selenium Nanoparticles onFrontiers in microbiology · 2020Article
- The Sialic Acid-Dependent Nematocyst Discharge Process in Relation to Its Physical-Chemical Properties Is A Role Model for Nanomedical Diagnostic and Therapeutic Tools.Marine drugs · 2019Article
- A Versatile Catalyst-Free Perfluoroaryl Azide-Aldehyde-Amine Conjugation Reaction.Materials chemistry frontiers · 2019Article
- Combatting antibiotic-resistant bacteria using nanomaterials.Chemical Society reviews · 2019Review
- Mesoporous Silica Materials as Drug Delivery: "The Nightmare" of Bacterial Infection.Pharmaceutics · 2018Review
- Magnetic Multivalent Trehalose Glycopolymer Nanoparticles for the Detection of Mycobacteria.Advanced healthcare materials · 2016Article
- Glyconanomaterials for biosensing applications.Biosensors & bioelectronics · 2016Review
- Aggregation-based detection of M. smegmatis using D-arabinose-functionalized fluorescent silica nanoparticles.Chemical communications (Cambridge, England) · 2015Article
- Glyconanomaterials for Combating Bacterial Infections.Chemistry (Weinheim an der Bergstrasse, Germany) · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
Silica and iron oxide nanoparticles with sizes ranging from 6 to 40 nm were functionalized with trehalose. The trehalose-conjugated nanoparticles showed strong interactions with Mycobacterium smegmatis (M. smegmatis) and minimal interactions with macrophage (RAW 264.7) or A549 cells. In addition, trehalose-conjugated silica nanoparticles selectively interacted with M. smegmatis on M. smegmatis-treated A549 cells, demonstrating high potential of trehalose in developing targeted therapy for treating mycobacterial infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.